Literature DB >> 32623788

Delta opioid receptor activation modulates affective pain and modality-specific pain hypersensitivity associated with chronic neuropathic pain.

Catherine M Cahill1, Sarah V Holdridge2, Shiwei Steve Liu1, Lihua Xue2, Claire Magnussen2, Edmund Ong2, Patrick Grenier2, Anne Sutherland2, Mary C Olmstead3.   

Abstract

Delta opioid receptor (DOR) agonists alleviate nociceptive behaviors in various chronic pain models, including neuropathic pain, while having minimal effect on sensory thresholds in the absence of injury. The mechanisms underlying nerve injury-induced enhancement of DOR function are unclear. We used a peripheral nerve injury (PNI) model of neuropathic pain to assess changes in the function and localization of DORs in mice and rats. Intrathecal administration of DOR agonists reversed mechanical allodynia and thermal hyperalgesia. The dose-dependent thermal antinociceptive effects of DOR agonists were shifted to the left in PNI rats. Administration of DOR agonists produced a conditioned place preference in PNI, but not in sham, animals, whereas the DOR antagonist naltrindole produced a place aversion in PNI, but not in sham, mice, suggesting the engagement of endogenous DOR activity in suppressing pain associated with the injury. GTPγS autoradiography revealed an increase in DOR function in the dorsal spinal cord, ipsilateral to PNI. Immunogold electron microscopy and in vivo fluorescent agonist assays were used to assess changes in the ultrastructural localization of DORs in the spinal dorsal horn. In shams, DORs were primarily localized within intracellular compartments. PNI significantly increased the cell surface expression of DORs within lamina IV-V dendritic profiles. Using neonatal capsaicin treatment, we identified that DOR agonist-induced thermal antinociception was mediated via receptors expressed on primary afferent sensory neurons but did not alter mechanical thresholds. These data reveal that the regulation of DORs following PNI and suggest the importance of endogenous activation of DORs in regulating chronic pain states.
© 2020 Wiley Periodicals LLC.

Entities:  

Keywords:  capsaicin; chronic pain; dorsal root ganglia; neuropathic pain; nociception; opiate; opioid; opioid receptor; pain; pain unpleasantness; peripheral nerve injury; spinal cord

Mesh:

Substances:

Year:  2020        PMID: 32623788      PMCID: PMC8218601          DOI: 10.1002/jnr.24680

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  56 in total

1.  Heterotopic inputs facilitate poststimulus afterdischarges of spinal WDR neurons in rats with chronic nerve constriction.

Authors:  Maria Luisa Sotgiu; Maurizio Valente; Gian Carlo Caramenti; Gabriele Eliseo Mario Biella
Journal:  Brain Res       Date:  2006-06-23       Impact factor: 3.252

Review 2.  Trafficking of delta-opioid receptors and other G-protein-coupled receptors: implications for pain and analgesia.

Authors:  Catherine M Cahill; Sarah V Holdridge; Anne Morinville
Journal:  Trends Pharmacol Sci       Date:  2006-12-05       Impact factor: 14.819

3.  Cutaneous wounds produced by capsaicin treatment of newborn rats are due to trophic disturbances.

Authors:  P Carrillo; M Camacho; J Manzo; M Martinez-Gomez; M Salas; P Pacheco
Journal:  Neurotoxicol Teratol       Date:  1998 Jan-Feb       Impact factor: 3.763

Review 4.  The delta opioid receptor: an evolving target for the treatment of brain disorders.

Authors:  Amynah A Pradhan; Katia Befort; Chihiro Nozaki; Claire Gavériaux-Ruff; Brigitte L Kieffer
Journal:  Trends Pharmacol Sci       Date:  2011-09-17       Impact factor: 14.819

5.  Nav1.8 expression is not restricted to nociceptors in mouse peripheral nervous system.

Authors:  Shannon D Shields; Hye-Sook Ahn; Yang Yang; Chongyang Han; Rebecca P Seal; John N Wood; Stephen G Waxman; Sulayman D Dib-Hajj
Journal:  Pain       Date:  2012-06-15       Impact factor: 6.961

6.  Genetic ablation of delta opioid receptors in nociceptive sensory neurons increases chronic pain and abolishes opioid analgesia.

Authors:  Claire Gaveriaux-Ruff; Chihiro Nozaki; Xavier Nadal; Xavier C Hever; Raphael Weibel; Audrey Matifas; David Reiss; Dominique Filliol; Mohammed A Nassar; John N Wood; Rafael Maldonado; Brigitte L Kieffer
Journal:  Pain       Date:  2011-02-03       Impact factor: 6.961

7.  Kappa Opioid Receptors Drive a Tonic Aversive Component of Chronic Pain.

Authors:  Shiwei Steve Liu; Sarah Pickens; Nicole E Burma; Ines Ibarra-Lecue; Hongyan Yang; Lihua Xue; Chris Cook; Joshua K Hakimian; Amie L Severino; Lindsay Lueptow; Kristina Komarek; Anna M W Taylor; Mary C Olmstead; F Ivy Carroll; Caroline E Bass; Anne M Andrews; Wendy Walwyn; Tuan Trang; Christopher J Evans; Frances M Leslie; Catherine M Cahill
Journal:  J Neurosci       Date:  2019-03-12       Impact factor: 6.167

8.  δ-Opioid receptor agonists inhibit migraine-related hyperalgesia, aversive state and cortical spreading depression in mice.

Authors:  Amynah A Pradhan; Monique L Smith; Jekaterina Zyuzin; Andrew Charles
Journal:  Br J Pharmacol       Date:  2014-05       Impact factor: 8.739

9.  Cocaine withdrawal-induced anxiety in females: impact of circulating estrogen and potential use of delta-opioid receptor agonists for treatment.

Authors:  Lisa M Ambrose-Lanci; R C Sterling; Elisabeth J Van Bockstaele
Journal:  J Neurosci Res       Date:  2010-03       Impact factor: 4.164

10.  The antiallodynic action of nortriptyline and terbutaline is mediated by β(2) adrenoceptors and δ opioid receptors in the ob/ob model of diabetic polyneuropathy.

Authors:  Nada Choucair-Jaafar; Eric Salvat; Marie-José Freund-Mercier; Michel Barrot
Journal:  Brain Res       Date:  2013-12-19       Impact factor: 3.252

View more
  3 in total

1.  Modulating β-arrestin 2 recruitment at the δ- and μ-opioid receptors using peptidomimetic ligands.

Authors:  Krishna K Sharma; Robert J Cassell; Yazan J Meqbil; Hongyu Su; Arryn T Blaine; Benjamin R Cummins; Kendall L Mores; David K Johnson; Richard M van Rijn; Ryan A Altman
Journal:  RSC Med Chem       Date:  2021-08-16

Review 2.  Intrathecal Drug Delivery: Advances and Applications in the Management of Chronic Pain Patient.

Authors:  Jose De Andres; Salim Hayek; Christophe Perruchoud; Melinda M Lawrence; Miguel Angel Reina; Carmen De Andres-Serrano; Ruben Rubio-Haro; Mathew Hunt; Tony L Yaksh
Journal:  Front Pain Res (Lausanne)       Date:  2022-06-16

3.  Exploration of beta-arrestin isoform signaling pathways in delta opioid receptor agonist-induced convulsions.

Authors:  Arryn T Blaine; Yiming Miao; Jinling Yuan; Sophia Palant; Rebecca J Liu; Zhong-Yin Zhang; Richard M van Rijn
Journal:  Front Pharmacol       Date:  2022-08-11       Impact factor: 5.988

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.